Related Experiment Video
Updated: Oct 1, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Multisystem thromboembolism in a COVID-19 patient: a case report
Moaaz Baghal1, Viralkumar Amrutiya1, Swati Govil1
1Internal Medicine Department, Hackensack Meridian Health Palisades Medical Center.
Insights
Managing hypercoagulability in COVID-19 patients is challenging. This case highlights deep venous thrombosis, pulmonary embolism, and stroke management complexities in a COVID-19 patient with cardiac anomalies, requiring thrombus aspiration.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- COVID-19 is associated with hypercoagulability, a significant factor in patient morbidity and mortality.
- Managing thromboembolic events in COVID-19 patients presents unique clinical challenges, especially with underlying cardiac conditions.
Abstract:
Hypercoagulability has been found in patients diagnosed with the novel coronavirus 19 (COVID-19) and has been identified as a major cause of morbidity and mortality. Herein, we report the challenge in managing a patient presenting with a 5 day history of COVID-19 diagnosis, complicated by deep venous thrombosis, pulmonary embolism and ischemic stroke in the setting of atrial septal aneurysm, presumed patent foramen ovale and paradoxical embolism, identified to have clots in transit on echocardiogram. The application of anticoagulation was felt to be high risk. The patient was transferred to a tertiary facility where the patient underwent thrombus aspiration and was eventually complicated by hemorrhagic conversion of the stroke.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

